Tempus AI , Inc. (NASDAQ:TEM) Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a recent SEC filing.The timing is notable as ...

The round also received backing from angel investors and healthcare pioneers, including Mario Schlosser, co-founder and former CEO of Oscar Health (NYSE: OSCR), Ryan Fukushima, COO of Tempus ...

The fundraise for Pathos AI, established by Ryan Fukushima and Eric Lefkofsky, pushes its valuation to $600 million. On the first day of Gov. JB Pritzker's trade mission to Japan, Sysmex America ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

Ryan Fukushima, the Chief Operating Officer of Tempus AI, Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings in the company. According to a filing with the... ByInvesting.com ...